Welcome to International Network for Natural Sciences | INNSpub

Prevalence, biochemical and hematological study of diabetic patients

Research Paper | January 1, 2017

| Download 15

Sibghat Ullah Khan, Asadullah, Faiz Ullah, Naveed Akhtar, Muhammad Fiaz Khan, Kausar Saeed

Key Words:

Int. J. Biomol. & Biomed.6( 1), 1-6, January 2017


IJBB 2017 [Generate Certificate]


Diabetes is a rapidly and serious health problem in Pakistan. This chronic condition is associated with serious long-term complications, including higher risk of heart disease and stroke. Aggressive treatment of hypertension and hyperlipideamia can result in a substantial reduction in cardiovascular events in patients with diabetes 1. Consequently pharmacist-led diabetes cardiovascular risk (DCVR) clinics have been established in both primary and secondary care sites in NHS Lothian during the past five years. An audit of the pharmaceutical care delivery at the clinics was conducted in order to evaluate practice and to standardize the pharmacists’ documentation of outcomes. Pharmaceutical care issues (PCI) and patient details were collected both prospectively and retrospectively from three DCVR clinics. The PCI`s were categorized according to a triangularised system consisting of multiple categories. These were ‘checks’, ‘changes’ (‘change in drug therapy process’ and ‘change in drug therapy’), ‘drug therapy problems’ and ‘quality assurance descriptors’ (‘timer perspective’ and ‘degree of change’). A verified medication assessment tool (MAT) for patients with chronic cardiovascular disease was applied to the patients from one of the clinics. The tool was used to quantify PCI`s and pharmacist actions that were centered on implementing or enforcing clinical guideline standards. A database was developed to be used as an assessment tool and to standardize the documentation of achievement of outcomes. Feedback on the audit of the pharmaceutical care delivery and the database was received from the DCVR clinic pharmacist at a focus group meeting.


Copyright © 2017
By Authors and International Network for
Natural Sciences (INNSPUB)
This article is published under the terms of the Creative
Commons Attribution Liscense 4.0

Prevalence, biochemical and hematological study of diabetic patients

Almawi WY, Tamim H, Azar ST. 1999. Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes. J Clin Endocrinol Metab 84, 1497-1502.

Amos AF, McCarty DJ, Zimmet P. 1997. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med, 14, S1-85.

Andrus M, Leggett-Frazier N, Pfeifer MA. 2003. Chronic complications of diabetes: an overview. American Association of Diabetes Educators, Chicago.

Atkinson MA, Maclaren NK. 1990. What causes diabetes? Sci Am 263, 62-63.

Beyan H, Buckley LR, Yousaf N, Londei M, Leslie RD. 2003. A role for innate immunity in type 1 diabetes? Diabetes Metab Res Rev 19, 89-100.

Delovitch TL, Singh B. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7, 727-738.

Elgert KD. 1996. Immunology : understanding the immune system. Wiley-Liss, New York USA.

Fowler MJ. 2008. Microvascular and Macrovascular Complications of Diabetes. Clinical Diabetes 26, 77-82.

Gadbsy R. 2002. Epidemiology of diabetes. Adv Drug Deliv Rev 54, 1165-72.

Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T, Taniguchi N. 1995. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes 44, 733-738.

Keller U. 2006. From obesity to diabetes. Int J Vitam Nutr Res 76, 172-177.

King H, Aubert RE, Herman WH. 1998. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21, 1414-31.

Kraine MR, Tisch RM. 1999. The role of environmental factors in insulin-dependent diabetes mellitus: an unresolved issue. Environ Health Perspect 107 Suppl 5, 777-781.

Krauss RM. 2004. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 27, 1496-1504.

McCarty D. 1994. Diabetes 1994 to 2010: global estimates and projects. International Diabetes Institute Melbourne.

Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA. 2006. Mortality in people with Type 2 diabetes in the UK. Diabet Med 23, 516-21.

Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. 1999. Worldwide increase in incidence of Type I diabetes–the analysis of the data on published incidence trends. Diabetologia 42, 1395-1403.

Passa P. 2002. Diabetes trends in Europe. Diabetes Metab Res Rev, 18, S3-8.

Rewers M, Norris J, Dabelea D. 2004. Epidemiology of Type 1 Diabetes Mellitus. In: Eisenbarth, G.S. (Ed.), Immunology of type 1 diabetes. Kluwer Academic/Plenum Publishers; Eurekah.com/Landes Bioscience, New York; Georgetown Tex.

Shera A, Rafique G, Khwaja IA, Baqai S, Khan I, King H, et al. 1999. Pakistan national diabetes survey: prevalence of glucose intolerance and associated factors in North West Frontier Province (NWFP) of Pakistan. J Pak Med Assoc 49, 206-11.

Shera AS, Jawad F, Maqsood A. 2007. Prevalence of diabetes in Pakistan, Diabetes Res Clin Pract, 76, 219-22.

Shera AS, Rafique G, Khwaja IA, Ara J, Baqai S, King H. 1995. Pakistan national diabetes survey: prevalence of glucose intolerance and associated factors in Shikarpur, Sindh Province. Diab Med 12, 1116-21.

Tisch R, McDevitt H. 1996. Insulin-dependent diabetes mellitus. Cell 85, 291-297.

Varughese GI, Tomson J, Lip GY. 2005. Type 2 diabetes mellitus: a cardiovascular perspective. Int J Clin Pract 59, 798-816.

Vinicor F. 2003. Macrovascular disease. American Association of Diabetes Educators Chicago.

Wannamethee SG, Shaper AG, Lennon L. 2004. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart 90, 1398-403.

Wild S, Roglic G, Green A, Sicree R, King H. 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care 27, 1047-53.

World Health Report. 2003. World health Organization (WHO). 1211 Geneva 27, Switzerland.

Zafar J, Bhatti F, Akhtar N, Rasheed U, Bashir R, Humayun S, Waheed A, Younus F, Nazar M, Umaima. 2011. Prevalence and risk factors for diabetes mellitus in a selected urban population of a city in Punjab. J Pak Med Assoc, Vol. 61, 40-47.